Aspirin Discontinuation in Elderly Stroke Patients

Risk Assessment and Management

In elderly patients (>75 years) with bleeding complications, the risk-benefit ratio of aspirin therapy shifts toward increased harm due to higher bleeding risk, according to the American Diabetes Association 2
The American College of Chest Physicians recommends stopping aspirin in patients with previous stroke who are experiencing bruising or bleeding, as the risks of continued bleeding may outweigh the benefits of stroke prevention in this scenario 1

For patients with non-cardioembolic ischemic stroke who cannot tolerate aspirin due to bleeding, the American Heart Association recommends clopidogrel 75mg daily as a reasonable alternative antiplatelet option 1, 3
If the patient has atrial fibrillation, the American Stroke Association recommends considering oral anticoagulation after the bleeding has resolved and risk has been reassessed 1, 4

In patients over 80 years old, the absolute benefit of antiplatelet therapy for stroke prevention must be carefully weighed against the significantly increased bleeding risk, according to the American Diabetes Association 2

After stopping aspirin, the American College of Chest Physicians recommends monitoring for resolution of bleeding/bruising complications, any signs of recurrent stroke symptoms, and overall cardiovascular status 1, 3

The American College of Chest Physicians recommends confirming active bleeding/bruising is related to aspirin use, stopping aspirin immediately if bleeding is significant or concerning, and evaluating severity and source of bleeding 1, 2
The American Heart Association recommends allowing time for bleeding to resolve (typically 1-2 weeks), reassessing stroke risk factors and need for antithrombotic therapy, and considering alternative antiplatelet agents if aspirin is contraindicated 1, 3